Cardiovascular Renal Metabolic

Kayo Waki , Shuya Iwata , Toshimasa Yamauchi , et al

Read time: 13m 32s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis

Ellen Apperloo

Watch time: 6m 37s
THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s
BPROAD: Promising Results for Intensive Blood Pressure Control in Type 2 Diabetes Patients

Radcliffe CVRM

AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s
AHA 24: The SELECT Trial

Subodh Verma

Watch time: 5m 7s
AHA 24 Late-Breaking Discussion: REALIZE-K

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s
AHA 24 Late-Breaking Discussion: The SUMMIT Trial

Harriette Van Spall, Milton Packer

Watch time: 17m 22s
AHA 24 Late-Breaking Discussion: The FLOW Trial

Harriette Van Spall,

Watch time: 16m 57s

David Wheeler, Carol Pollock et al

Muthiah Vaduganathan

Sydney Tang et al

Andrew JS Coats, Stefan Anker

David Tak Wai Lui , Junya Ako , Jamshed Dalal , et al

Read time: 20m 26s
ESC 2021 Discussion: The EMPEROR-Preserved Trial

Stefan Anker, Harriette Van Spall

Watch time: 19m 47s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s

James Burton

Watch time: 4m 58s (1 video)
ESC 2021 Discussion: The FIGARO-DKD Trial

Bertram Pitt, Harriette Van Spall

Watch time: 15m 2s
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen

Watch time: 24m 27s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
EASD 22: SURMOUNT-MMO: Tirepatide in Obese Type II Diabetes Patients

Steven E Nissen

Watch time: 7m 48s

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur

Watch time: 14m 20s
AHA 22: BT001 PIVOTAL: nCBT in Pts with Type II Diabetes

Marc P Bonaca

Watch time: 7m 23s

Media

ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis

Ellen Apperloo

Watch time: 6m 37s
ACC 24 Late-Breaker Discussion: The ARISE-HF Trial

Harriette Van Spall, James L Januzzi

Watch time: 23m 6s
ESC 2021 Discussion: The EMPEROR-Preserved Trial

Stefan Anker, Harriette Van Spall

Watch time: 19m 47s
EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFpEF

Javed Butler

Watch time: 6m 35s
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen

Watch time: 24m 27s
EASD 22: Efficacy of Ertugliflozin Across the Spectrum of EF in HF

Ambarish Pandey

Watch time: 3m 5s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s

Articles

Digital Therapeutics and Type 2 Diabetes

Kayo Waki

,

Shuya Iwata

,

Toshimasa Yamauchi

,

Masaomi Nangaku

,

Kazuhiko Ohe

,

Published:

10 April 2025

Citation:

Journal of Asian Pacific Society of Cardiology 2025;4:e09.

DOI:

https://doi.org/10.15420/japsc.2024.34
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 122
  • Downloads: Downloads 11
  • Read time: 13m 32s

Obesity in Asia-Pacific

David Tak Wai Lui

,

Junya Ako

,

Jamshed Dalal

,

Alan Fong

,

Masashi Fujino

,

Ari Horton

,

Rungroj Krittayaphong

,

Wael Almahmeed

,

Anne Thushara Matthias

,

Adam J Nelson

,

Stephen Nicholls

,

Richard O’Brien

,

Kian Keong Poh

,

Khalida Soomro

,

Khung Keong Yeo

,

Kathryn Choon Beng Tan

,

Published:

05 June 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e21.

DOI:

https://doi.org/10.15420/japsc.2023.68
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 8823
  • Downloads: Downloads 91
  • Citations: 6
  • Read time: 20m 26s

Cardiometabolic Risk Factors and COVID-19 in the Asia-Pacific Region

Ru Ying Fong

,

Annie Lee

,

Fei Gao

,

Jonathan Jiunn Liang Yap

,

Khung Keong Yeo

,

Published:

23 June 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e22.

DOI:

https://doi.org/10.15420/japsc.2022.27
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 674
  • Downloads: Downloads 16
  • Citations: 1
  • Read time: 18m

Diastolic Function Criteria & Outcomes Prediction in Patients with Diabetes

Diana Hui Ping Foo

,

Kai Huat Lam

,

Macnicholson Igo

,

Mohammad Nor Azlan Bin Sulaiman

,

Mohamad Adam Bin Bujang

,

Ming Ying Ku

,

Teck Long King

,

Rose Hui Chin Jong

,

Sally Suriani Ahip

,

Mohammad Faiz Sahiran

,

Maila Mustapha

,

Jennett Michael

,

Azreen Abdullah

,

Alan Yean Yip Fong

,

Published:

26 July 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e16.

DOI:

https://doi.org/10.15420/japsc.2021.25
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 972
  • Downloads: Downloads 39
  • Read time: 20m